Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 13, 2020

SELL
$72.34 - $84.0 $5.09 Million - $5.91 Million
-70,306 Closed
0 $0
Q1 2020

Apr 29, 2020

SELL
$62.63 - $80.22 $200,353 - $256,623
-3,199 Reduced 4.35%
70,306 $5.26 Million
Q4 2019

Jan 21, 2020

SELL
$61.62 - $67.78 $95,018 - $104,516
-1,542 Reduced 2.05%
73,505 $4.78 Million
Q3 2019

Nov 06, 2019

BUY
$62.51 - $69.0 $1.7 Million - $1.87 Million
27,163 Added 56.73%
75,047 $4.76 Million
Q2 2019

Jul 19, 2019

BUY
$61.87 - $69.38 $115,016 - $128,977
1,859 Added 4.04%
47,884 $3.24 Million
Q1 2019

Jul 01, 2019

SELL
$62.53 - $70.05 $130,562 - $146,264
-2,088 Reduced 4.34%
46,025 $2.99 Million
Q4 2018

Jan 15, 2019

BUY
$60.54 - $79.0 $50,127 - $65,412
828 Added 1.75%
48,113 $3.01 Million
Q3 2018

Oct 23, 2018

BUY
$71.28 - $78.92 $3.16 Million - $3.5 Million
44,372 Added 1523.24%
47,285 $3.65 Million
Q2 2018

Jul 19, 2018

SELL
$64.88 - $75.68 $240,055 - $280,016
-3,700 Reduced 55.95%
2,913 $206,000
Q1 2018

Apr 20, 2018

BUY
$72.84 - $88.8 $26,950 - $32,856
370 Added 5.93%
6,613 $499,000
Q4 2017

Feb 13, 2018

SELL
$71.15 - $83.52 $26,325 - $30,902
-370 Reduced 5.6%
6,243 $447,000
Q3 2017

Oct 23, 2017

BUY
$72.11 - $85.47 $476,863 - $565,213
6,613
6,613 $536,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Prentiss Smith & CO Inc Portfolio

Follow Prentiss Smith & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentiss Smith & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prentiss Smith & CO Inc with notifications on news.